Sureja D - Search Results

1

A review of efficacy and safety of cetuximab and bevacizumab-based monoclonal antibodies in head and neck cancer.

Khadela A, Shah Y, Mistry P, Mansuri M, Sureja D, Bodiwala K. Khadela A, et al. Among authors: sureja d. Med Oncol. 2022 Dec 30;40(1):66. doi: 10.1007/s12032-022-01939-x. Med Oncol. 2022. PMID: 36583766 Review.

2

Simultaneous Estimation of Six Nitrosamine Impurities in Valsartan Using Liquid Chromatographic Method.

Bodiwala KB, Panchal BG, Savale SS, Dave JB, Sureja DK, Dhameliya TM, Chhabria MT. Bodiwala KB, et al. Among authors: sureja dk. J AOAC Int. 2022 Feb 4;105(1):1-10. doi: 10.1093/jaoacint/qsab100. J AOAC Int. 2022. PMID: 34338773

3

A decennary update on applications of metal nanoparticles (MNPs) in the synthesis of nitrogen- and oxygen-containing heterocyclic scaffolds.

Dhameliya TM, Donga HA, Vaghela PV, Panchal BG, Sureja DK, Bodiwala KB, Chhabria MT. Dhameliya TM, et al. Among authors: sureja dk. RSC Adv. 2020 Sep 3;10(54):32740-32820. doi: 10.1039/d0ra02272a. eCollection 2020 Sep 1. RSC Adv. 2020. PMID: 35516511 Free PMC article. Review.

4

In-silico Computational Investigations of AntiViral Lignan Derivatives as Potent Inhibitors of SARS CoV-2.

Sureja DK, Shah AP, Gajjar ND, Jadeja SB, Bodiwala KB, Dhameliya TM. Sureja DK, et al. ChemistrySelect. 2022 Jul 27;7(28):e202202069. doi: 10.1002/slct.202202069. Epub 2022 Jul 26. ChemistrySelect. 2022. PMID: 35942360 Free PMC article.

5

Impact of cetuximab plus cisplatin alone and cetuximab plus cisplatin and paclitaxel regimen on humanistic outcome in head and neck cancer.

Khadela A, Vyas B, Mansuri M, Sureja D, Bodiwala K. Khadela A, et al. Among authors: sureja d. J Egypt Natl Canc Inst. 2023 Jan 19;35(1):1. doi: 10.1186/s43046-023-00160-9. J Egypt Natl Canc Inst. 2023. PMID: 36656444

6

A Review on DNA Repair Inhibition by PARP Inhibitors in Cancer Therapy.

Shah AP, Patel CN, Sureja DK, Sanghavi KP. Shah AP, et al. Among authors: sureja dk. Folia Med (Plovdiv). 2018 Mar 1;60(1):39-47. doi: 10.1515/folmed-2017-0067. Folia Med (Plovdiv). 2018. PMID: 29668451 Review.

7

Synthesis of some novel pyrazolo[3,4-d] pyrimidin-4(5H)-one derivatives as potential antimicrobial agent.

Sureja DK, Dholakia SP, Vadalia KR. Sureja DK, et al. J Pharm Bioallied Sci. 2016 Oct-Dec;8(4):321-326. doi: 10.4103/0975-7406.199337. J Pharm Bioallied Sci. 2016. PMID: 28216957 Free PMC article.

8

Synthesis and QSAR studies of 4-substituted phenyl-2,6-dimethyl-3, 5-bis-N-(substituted phenyl)carbamoyl-1,4-dihydropyridines as potential antitubercular agents.

Desai B, Sureja D, Naliapara Y, Shah A, Saxena AK. Desai B, et al. Among authors: sureja d. Bioorg Med Chem. 2001 Aug;9(8):1993-8. doi: 10.1016/s0968-0896(01)00141-9. Bioorg Med Chem. 2001. PMID: 11504636

9

6,12-dihydro-1-benzopyrano[3,4-b][1,4]benzothiazin-6-ones: synthesis and mdr reversal in tumor cells.

Shah A, Naliapara Y, Sureja D, Motohashi N, Kawase M, Miskolci C, Szabo D, Molnár J. Shah A, et al. Among authors: sureja d. Anticancer Res. 1998 Jul-Aug;18(4C):3001-4. Anticancer Res. 1998. PMID: 9713499

10

Biological activity of 6,12-dihydro-1-benzopyrano[3,4-b][1,4]benzothiazin-6-ones.

Shah A, Naliapara Y, Sureja D, Motohashi N, Kurihara T, Kawase M, Satoh K, Sakagami H, Molnár J. Shah A, et al. Among authors: sureja d. Anticancer Res. 1998 Jan-Feb;18(1A):61-3. Anticancer Res. 1998. PMID: 9568056

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

10 results

Search Page

Filters